- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cellular immunotherapy for refractory hematological malignancies ; volume:11 ; number:1 ; day:19 ; month:6 ; year:2013 ; pages:1-9 ; date:12.2013
Journal of translational medicine ; 11, Heft 1 (19.6.2013), 1-9, 12.2013
- Urheber
-
Reagan, John L.
- Beteiligte Personen und Organisationen
-
Fast, Loren D.
Safran, Howard
Nevola, Martha
Winer, Eric S.
Castillo, Jorge J.
Butera, James N.
Quesenberry, Matthew I.
Young, Carolyn T.
Quesenberry, Peter J.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-11-150
- URN
-
urn:nbn:de:1111-2016041446714
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Reagan, John L.
- Fast, Loren D.
- Safran, Howard
- Nevola, Martha
- Winer, Eric S.
- Castillo, Jorge J.
- Butera, James N.
- Quesenberry, Matthew I.
- Young, Carolyn T.
- Quesenberry, Peter J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advances in nano-immunotherapy for hematological malignancies
“A.B.C.” of Immunotherapy in Hematological Malignancies…Promise and Perils
Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies
The landscape overview of CD47-based immunotherapy for hematological malignancies
Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Advances in nano-immunotherapy for hematological malignancies
“A.B.C.” of Immunotherapy in Hematological Malignancies…Promise and Perils
Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies
The landscape overview of CD47-based immunotherapy for hematological malignancies
Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Advances in nano-immunotherapy for hematological malignancies
“A.B.C.” of Immunotherapy in Hematological Malignancies…Promise and Perils
Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies
The landscape overview of CD47-based immunotherapy for hematological malignancies
Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies